Involvement of the mitochondrial apoptotic pathway and nitric oxide synthase in dopaminergic neuronal death induced by 6-hydroxydopamine and lipopolysaccharide

References

• Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 1990; 54: 823–827.
   PubMed Web of Science ®Google Scholar
• de la Monte SM, Sohn YK, Ganju N, Wands JR. P53- and CD95-associated apoptosis in neurodegenerative diseases. Lab Invest 1998; 78: 401–411.
   PubMed Web of Science ®Google Scholar
• Hartmann A, Hunot S, Michel PP et al. Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc Natl Acad Sci USA 2000; 97: 2875–2880.
   PubMed Web of Science ®Google Scholar
• Mogi M, Togari A, Kondo T et al. Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from parkinsonian brain. J Neural Transm 2000; 107: 335–341.
   PubMed Web of Science ®Google Scholar
• Hartmann A, Troadec JD, Hunot S et al. Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis. J Neurosci 2001; 21: 2247–2255.
   PubMed Web of Science ®Google Scholar
• Lee DH, Han YS, Han ES, Bang H, Lee CS. Differential involvement of intracellular Ca2* in 1-methyl-4-phenylpyridinium- or 6-hydroxy-dopamine-induced cell viability loss in PC12 cells. Neurochem Res 2006; 31: 851–860.
   PubMed Web of Science ®Google Scholar
• Singh S, Dikshit M. Apoptotic neuronal death in Parkinson's disease: involvement of nitric oxide. Brain Res Rev 2007; 54: 233–250.
   PubMed Web of Science ®Google Scholar
• Takai N, Nakanishi H, Tanabe K et al. Involvement of caspase-like proteinases in apoptosis of neuronal PC12 cells and primary cultured microglia induced by 6-hydroxydopamine. J Neurosci Res 1998; 54: 214–222.
   PubMed Web of Science ®Google Scholar
• Fall CP, Bennett JP Jr. Characterization and time course of MPP*-induced apoptosis in human SH-SY5Y neuroblastoma cells. J Neurosci Res 1999; 55: 620–628.
   PubMed Web of Science ®Google Scholar
• Blum D, Torch S, Lambeng N et al. Molecular pathways involved in the neurotoxicity of 6-0HDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 2001; 65: 135–172.
   PubMed Web of Science ®Google Scholar
• Von Coelln R, Kugler S, Bahr M, Weller M, Dichgans J, Schulz JB. Rescue from death but not from functional impairment: caspase inhibition protects dopaminergic cells against 6-hydroxydopamine-induced apoptosis but not against the loss of their terminals. J Neurochem 2001; 77: 263–273.
   PubMed Web of Science ®Google Scholar
• Gomez C, Reiriz J, Pique M, Gil J, Ferrer I, Ambrosio S. Low concentrations of 1-methyl-4-phenylpyridinium ion induce caspase-mediated apoptosis in human SH-SY5Y neuroblastoma cells. J Neurosci Res 2001; 63: 421–428.
   PubMed Web of Science ®Google Scholar
• Han BS, Hong HS, Choi WS, Markelonis GJ, Oh TH, Oh YJ. Caspase-dependent and independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment. J Neurosci 2003; 23: 5069–5078.
   PubMed Web of Science ®Google Scholar
• Noelker C, Bacher M, Gocke P et al. The flavanoide caffeic acid phenethyl ester blocks 6-hydroxydopamine-induced neurotoxicity. Neurosci Lett 2005; 383: 39–43.
   PubMed Web of Science ®Google Scholar
• Blum D, Wu Y, Nissou MF, Arnaud S, Alim Louis B, Verna JM. p53 and Bax activation in 6-hydroxydopamine-induced apoptosis in PC12 cells. Brain Res 1997; 751: 139–142.
   PubMed Web of Science ®Google Scholar
• Jordan J, Galindo MF, Tomero D, Gonzalez-Garcia C, Cena V. Bc1-xl blocks mitochondrial multiple conductance channel activation and inhibits 6-0HDA-induced death in SH-SY5Y cells. J Neurochem 2004; 89: 124–133.
   PubMed Web of Science ®Google Scholar
• Cutillas B, Espejo M, Gil J, Ferrer I, Ambrosio S. Caspase inhibition protects nigral neurons against 6-0HDA-induced retrograde degeneration. Neuroreport 1999; 10: 2605–2608.
   PubMed Web of Science ®Google Scholar
• Raghavan SA, Dikshit M. Vascular regulation by the L-arginine metabolites, nitric oxide and agmatine. Pharmacol Res 2004; 49: 397–414.
   PubMed Web of Science ®Google Scholar
• Kavya R, Saluja R, Singh S, Dikshit M. Nitric oxide synthase regulation and diversity: implications in Parkinson's disease. Nitric Oxide 2006; 15: 280–294.
   PubMed Web of Science ®Google Scholar
• Duncan AJ, Heales SJ. Nitric oxide and neurological disorders. Mol Aspects Med 2005; 26: 67–96.
   PubMedGoogle Scholar
• Zhang L, Dawson VL, Dawson TM. Role of nitric oxide in Parkinson's disease. Pharmacol Ther 2006; 109: 33–41.
   PubMed Web of Science ®Google Scholar
• Heales SJ, Bolanos JP, Stewart VC, Brookes PS, Land JM, Clark JB. Nitric oxide, mitochondria and neurological disease. Biochim Biophys Acta 1999; 1410: 215–228.
   PubMed Web of Science ®Google Scholar
• Barthwal MK, Srivastava N, Dikshit M. Role of nitric oxide in a progressive neurodegeneration model of Parkinson's disease in the rat. Redox Report 2001; 6: 297–302.
   PubMed Web of Science ®Google Scholar
• Singh S, Das T, Ravindran A et al. Involvement of nitric oxide in neurodegeneration: a study on the experimental models of Parkinson's disease Redox Report 2005; 10: 103–109.
   Google Scholar
• Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates, 2nd edn. New York: Academic Press, 1982; 83-97.
   Google Scholar
• Yokoyama C, Okamura H. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 1. Dopaminergic neurons and receptors. J Pharmacol Exp Ther 1997; 280: 1016–1030.
   PubMed Web of Science ®Google Scholar
• Rajapakse N, Shimizu K, Payne M, Busija D. Isolation and characterization of intact mitochondria from neonatal rat brain. Brain Res Protocol 2001; 8: 176–183.
   PubMedGoogle Scholar
• Fujimura M, Morita-Fujimura Y, Murakami K, Kawase M, Chan PH. Cytosolic redistribution of cytochrome c after transient focal cerebral ischemia in rats. J Cerebr Blood Flow Metab 1998; 18: 1239–1247.
   PubMed Web of Science ®Google Scholar
• Heneka MT, Sastre M, Dumitrescu-Ozimek L et al. Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V7171] transgenic mice. J Neuroinflamm 2005; 2: 22.
   PubMedGoogle Scholar
• Cid C, Alvarez-Cermeno JC, Regidor I, Plaza J, Salinas M, Alcazar A. Caspase inhibitors protect against neuronal apoptosis induced by cerebrospinal fluid from multiple sclerosis patients. J Neuroimmunol 2003; 136: 119–124.
   PubMed Web of Science ®Google Scholar
• Castano A, Herrera AJ, Cano J, Machado A. Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system. J Neurochem 1998; 70: 1584–1592.
   PubMed Web of Science ®Google Scholar
• Sanchez-Pemaute R, Ferree A, Cooper O, Yu M, Brownell AL, Isacson O. Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease. J Neuroinflamm 2004; 1: 6.
   PubMedGoogle Scholar
• Chung HT, Pae HO, Choi BM, Billiar TR, Kim YM. Nitric oxide as a bioregulator of apoptosis. Biochem Biophys Res Commun 2001; 282: 1075–1079.
   PubMed Web of Science ®Google Scholar
• Kim PK, Zamora R, Petrosko P, Billiar TR. The regulatory role of nitric oxide in apoptosis. Int Immunopharmacol 2001; 1: 1421–1441.
   PubMed Web of Science ®Google Scholar
• Paucard A, Palmier B, Croci N, Taillieu F, Plotkine M, Margaill I. Biphasic modulation by nitric oxide of caspase activation due to malonate injection in rat striatum. Eur J Pharmacol 2004; 483: 259–265.
   PubMed Web of Science ®Google Scholar
• Kitamura Y, Inden M, Miyamura A, Kakimura J, Taniguchi T, Shimohama S. Possible involvement of both mitochondria- and endoplasmic reticulum-dependent caspase pathways in rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurosci Lett 2002; 333: 25–28.
   PubMed Web of Science ®Google Scholar
• Hanrott K, Gudmunsen L, O'Neill MJ, Wonnacott S. 6-Hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase Cdelta. J Biol Chem 2006; 281: 5373–5382.
   PubMed Web of Science ®Google Scholar
• Navarro A, Boveris A, Bandez MJ et al. Human brain cortex: mitochondrial oxidative damage and adaptive response in Parkinson disease and in dementia with Lewy bodies. Free Radic Biol Med 2009; 46: 1574–1580.
   PubMed Web of Science ®Google Scholar
• Brown GC, Borutaite V. Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols. Biochim Biophys Acta 2004; 1658: 11 49.
   Google Scholar
• Von Ahsen 0, Waterhouse NJ, Kuwana T, Newmeyer DD, Green DR. The ‘harmless’ release of cytochrome c. Cell Death Diff 2000; 7: 1192–1199.
   PubMed Web of Science ®Google Scholar
• Donovan M, Cotter TG. Control of mitochondrial integrity by Bc1-2 family members and caspase-independent cell death. Biochim Biophys Acta 2004; 1644: 133–147.
   PubMed Web of Science ®Google Scholar
• Munno I, Pellegrino NM, Marcuccio C, Conrotto L, Jirillo E, Covelli V. Neurological damage mediated by cytokines. Acta Neurol (Napoli) 1992; 14: 81–89.
   PubMedGoogle Scholar
• Ashe PC, Berry MD. Apoptotic signaling cascades. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 199–214.
   PubMed Web of Science ®Google Scholar